• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    CTI BioPharma Corp. (CTIC)

    -NasdaqCM
    1.71 Down 0.03(1.72%) 4:00PM EDT
    |After Hours : 1.69 Down 0.02 (1.11%) 5:29PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:1.74
    Open:1.75
    Bid:1.70 x 40000
    Ask:1.78 x 5800
    1y Target Est:5.30
    Beta:1.64
    Earnings Date:Aug 3 - Aug 7 (Est.)
    Day's Range:1.69 - 1.76
    52wk Range:1.69 - 3.23
    Volume:1,882,938
    Avg Vol (3m):3,437,440
    Market Cap:308.22M
    P/E (ttm):N/A
    EPS (ttm):-0.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CTIC

    Comparison

    Symbol% ChgMkt Cap
    CTICDown 1.72%308.22M
    BMYDown 0.86%113.85B
    RHHBYDown 0.94%N/A
    SNYDown 1.01%132.66B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.93
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.36
    Quarterly EPS Est (Jun-15) :-0.14
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback